Search
for
Sort by
Research 271–300 of 1000+
- Molecular mediators involved in skin healing: a narrative review
- Mesenchymal Stem Cells from Mouse Hair Follicles Inhibit the Development of Type 1 Diabetes
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
- 576 INTASYL PH-762: Intratumoral immunotherapy targeting PD-1
- Transcriptomic characterization of Lonrf1 at the single-cell level under pathophysiological conditions
- Reversible alopecia universalis secondary to PEG-interferon ??-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection
- Autologous stem cell-based interventions in Australia: exploring patient experience in light of regulatory exceptionalism
- Plasmacytoid dendritic cells in alopecia areata: missing link?
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Decreased CD200R expression on monocyte-derived macrophages correlates with Th17/Treg imbalance and disease activity in rheumatoid arthritis patients
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Selling stem cells in Australia: assessing the impact of new advertising standards on business practices
- 1325 Age-dependent loss of the stemness and antimicrobial defense function of dermal fibroblasts is mediated by TGFbeta
- Sterol Intermediates of Cholesterol Biosynthesis Inhibit Hair Growth and Trigger an Innate Immune Response in Cicatricial Alopecia
- Irreversible alopecia universalis during treatment with pegylated interferon-ribavirin for chronic hepatitis C virus infection: Case report and published work review
- Skin involvement in systemic lupus erythematosus: a review article
- Indications for a brain‐hair follicle axis: inhibition of keratinocyte proliferation and up‐regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- Three cases of immune‐mediated adnexal skin disease treated with cyclosporin
- Regulatory T cells are required for normal and activin‐promoted wound repair in mice
- Treatment of alopecia areata in pre‐adolescent children with oral tofacitinib: A retrospective study
- Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- Balance of tofacitinib efficacy and disease flare in the treatment of alopecia universalis: A case report and review of the literature
- The role of vasoactive peptides in skin homeostasis—focus on adiponectin and the kallikrein-kinin system
- Treatment of Severe Alopecia Areata: Combination Therapy Using Systemic Cyclosporine A with Low Dose Corticosteroids
- Oxidative stress and alopecia areata
- Increase in IL-15 levels in patients with alopecia areata
- Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy